For a moment, I thought that the price had reached the level at which Rick must improve his profile page! <g>
And now for the replay info.
Harry H. Penner, Jr., Neurogen's president and CEO, will host a conference call to discuss the start of Phase II studies with NGD 91-3 on Wednesday November 29, 2000 at 11:00 am EST. The call will be broadcast live via the internet at neurogen.com in the Investor Relations section, and will be archived on the website for at least one week following the call. A replay of the call will also be accessible by telephone after 1:00 p.m. EST, available until midnight December 1, 2000. To replay the call, dial 719-457- 0820, both in the U.S. and internationally, using the pass code 478354.
Stephen R. Davis, Neurogen's Senior Vice President and Chief Business Officer, will be discussing Neurogen's business and the Phase II trial start at the Robertson Stephens Medical Conference at 11:00 a.m. EST on November 30, 2000 at The Pierre in New York City.
Jim |
